Profile
ALGS VRTX REGN VRNA ARGX ALNY
Company Name Aligos Therapeutics, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $45.91M $122.53B $81.42B $72.68B $51.58B $43.35B
Employees 0.07K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Lawrence Blatt Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
ALGS VRTX REGN VRNA ARGX ALNY
Quant Rating Score 2 4 4 1 4 3
Quant Rating Sell Buy Buy Strong Sell Buy Neutral
Trading
ALGS VRTX REGN VRNA ARGX ALNY
Last Close $7.02 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $45.62 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $3.99 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -84.61 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 75.94 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
ALGS VRTX REGN VRNA ARGX ALNY
1 Month Return -29.73 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return -19.95 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return 20.21 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return -69.2 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return -82.38 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return -62.05 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ALGS VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -212.23 % 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Profitability
ALGS VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM 90.21 % 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -78.77 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM -132.42 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -98.81 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 100.36 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 99.33 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM -3277.93 % 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM -1305.21 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM - 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM 0.06 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM - 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM 47.12 % 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM 2.41 % 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -7.63 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -7.67 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 955.65 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM -2991.72 % 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.47 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM -1305.21 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -0.58 36.72 19.95 -995.27 129.37 195.85
Price To Operating Cash Flows Ratio TTM -0.98 32.86 16.2 -126.33 146.05 162.25
Price Cash Flow Ratio TTM -0.98 32.86 16.2 -126.33 146.05 162.25
Income Statement (TTM)
ALGS VRTX REGN VRNA ARGX ALNY
Revenue $0B $12B $14.34B $0.03B $2.19B $3.71B
Gross Profit $0B $10.35B $12.24B $0.03B $1.96B $3.04B
Gross Profit Ratio 100% 86.24% 85.35% 93.89% 89.62% 81.77%
EBITDA $-0.09B $4.69B $5.82B $-0.12B $0.11B $0.56B
Net Income $-0.13B $3.95B $4.5B $-0.14B $0.83B $0.31B
EPS Diluted -20.94 15.32 41.48 -1.73 12.78 2.33
Balance Sheet (MRQ)
ALGS VRTX REGN VRNA ARGX ALNY
Long Term Debt $0B $3.69B $2.71B $0.12B $0.03B $2.7B
Total Liabilities $0.1B $6.98B $9.3B $0.27B $0.7B $4.18B
Total Equity $-0.03B $18.67B $31.26B $0.2B $5.5B $0.79B
Total Investments $0.02B $5.71B $15.75B $0.02B $1.93B $1.25B
Total Debt $0.01B $3.69B $2.71B $0.12B $0.04B $2.97B
Total Assets $0.07B $25.64B $40.56B $0.47B $6.2B $4.97B
Cash Flow Statement (TTM)
ALGS VRTX REGN VRNA ARGX ALNY
Net Income $-0.13B $-0.54B $4.5B $-0.17B $0.83B $0.31B
Inventory $0B $-0.52B $-0.28B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $-0.08B $-0.49B $4.98B $-0.12B $-0.08B $0.52B
Capital Expenditure $-0B $-0.3B $-0.9B $-0B $-0.07B $-0.06B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 24.69
AARD Aardvark Therapeutics, Inc. Common Stock 12.14
ABCL AbCellera Biologics Inc. 3.111
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.005
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.505
ABPWW 0.0131
ABSI Absci Corporation 2.545
ABUS Arbutus Biopharma Corporation 3.99
ABVC ABVC BioPharma, Inc. 1.67
ABVX Abivax SA American Depositary Shares 124.925
ACAD ACADIA Pharmaceuticals Inc. 22.04
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 6.84
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.205
ACIU AC Immune SA 2.98
ETFs With Exposure to ALGS
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0.00005 336.66
IBB iShares Biotechnology ETF 0 172.59
SCHA Schwab U.S. Small-Cap ETF 0.00127187 30.61
VHT Vanguard Health Care Index Fund 0 290.43
BIB ProShares Ultra Nasdaq Biotechnology 0 84.7
VXF Vanguard Extended Market Index Fund 0.00052 216.22
IWC iShares Micro-Cap ETF 0.00379 166.14
VFLQ Vanguard U.S. Liquidity Factor ETF 0.1 99.7611
VUN.TO Vanguard U.S. Total Market Index ETF 0.00005 124.53
VUS.TO Vanguard U.S. Total Market Index ETF (CAD-hedged) 0.00005 116.8
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 113.17
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 113.15
VSTCX Vanguard Strategic Small-Cap Equity Fund Investor Shares 0.01 44.34
VBAIX Vanguard Balanced Index Fund Institutional Shares 0.00007 52.12
VBIAX Vanguard Balanced Index Fund Admiral Shares 0.00007 52.11
VBINX Vanguard Balanced Index Fund Investor Shares 0.00007 52.11
VGRO.TO Vanguard Growth ETF Portfolio 0.00002 44.16
GERM ETFMG Treatments, Testing and Advancements ETF 0.08 19.1577
VEQT.TO Vanguard All-Equity ETF Portfolio 0.00002 55.46
VBAL.TO Vanguard Balanced ETF Portfolio 0.00001 37.77
VCNS.TO Vanguard Conservative ETF Portfolio 0.00001 32.11
VCIP.TO Vanguard Conservative Income ETF Portfolio 0.00001 27.4
VRIF.TO Vanguard Retirement Income ETF Portfolio 0 27.01
DFAU Dimensional US Core Equity Market ETF 0.00001346 47.305
IBBQ Invesco Nasdaq Biotechnology ETF 0 29.45
DFAT Dimensional U.S. Targeted Value ETF 0.00001736 66.295
DFAS Dimensional U.S. Small Cap ETF 0.00001267 75.64
VTSAX Vanguard Total Stock Market Index Fund 0.00005 163.59
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0 8.7175
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00052 162.32
VITSX Vanguard Total Stock Market Index Fund 0.00005 163.62
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.0000792912 16.42
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00052 162.33
VHCIX Vanguard HealthCare Index Fund Admiral Shs 0 143.93
JKJ iShares Morningstar Small-Cap ETF 0.01 231.193
AVSC Avantis U.S. Small Cap Equity ETF 0 64.8
VTS.AX Vanguard US Total Market Shares Index ETF 0.00005 474.81
DCOR Dimensional ETF Trust 0.00033066 75.47
VEMPX Vanguard Extended Market Index InstlPlus 0.00052 400.57
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00005 306.93
Unlock